Miniatura

Fitxers

256609.pdf (644.52 KB)
Corrigendum Neoadjuvant endocrine therapy.pdf (257.85 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2023-01-01

Llicència de publicació

cc-by (c) Sirico, Marianna et al., 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/214184

Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.critrevonc.2022.103900

Resum

Neoadjuvant endocrine treatment (NET) associates to satisfactory rates of breast conservative surgery and conversions from inoperable to operable hormone receptor-positive (HR+)/HER2-negative breast cancer (BC), with less toxicities than neoadjuvant chemotherapy (NACT) and similar outcomes. Hence, it has been proposed as a logical alternative to NACT in patients with HR+/HER2- BC candidate to a neoadjuvant approach. Nevertheless, potential barriers to the widespread use of NET include the heterogeneous nature of patient response coupled with the long duration needed to achieve a clinical response. However, interest in NET has significantly increased in the last decade, owing to more in-depth investigation of several biomarkers for a more adequate patient selection and on-treatment benefit monitoring, such as PEPI score, Ki67 and genomic assays. This review is intended to describe the state-of-the-art regarding NET, its future perspectives and potential integration with molecular biomarkers for the optimal selection of patients, regimen and duration of (neo)adjuvant treatments.

Matèries

Càncer de mama, Marcadors bioquímics, Endocrinologia, Tractament adjuvant del càncer

Matèries (anglès)

Breast cancer, Biochemical markers, Endocrinology, Adjuvant treatment of cancer

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

SIRICO, Marianna, VIRGA, Alessandra, CONTE, Benedetta, URBINI, Milena, ULIVI, Paola, GIANNI, Caterina, MERLONI, Filippo, PALLESCHI, Michela, GASPERONI, Marco, CURCIO, Annalisa, SAHA, Debjani, BUONO, Giuseppe, MUÑOZ, Montserrat, DE GIORGI, Ugo, SCHETTINI, Francesco. Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives. _Critical Reviews in Oncology Hematology_. 2023. Vol. 181. [consulta: 21 de gener de 2026]. ISSN: 1040-8428. [Disponible a: https://hdl.handle.net/2445/214184]

Exportar metadades

JSON - METS

Compartir registre